Congress will have to debate whether pandemic era telehealth reimbursement and relaxation of rules should be made permanent. Given that those rules helped historically underserved populations access care as well as those seeking mental health services, experts believe there's too much to lose to simply go back to the old ways.
Braeden Lichti, a Canadian investor and co-founder of a private investment firm has launched several healthcare companies, talks about how he got his start.
Jazz Pharmaceuticals is licensing rights to a Werewolf Therapeutics cytokine therapy that's on track to reach clinical testing next year. The deal gives Jazz a drug candidate that expands the company's scope to immuno-oncology.
A new report that showed a sharp increase in cybersecurity attacks in 2021 urged organizations to consider when, not if, they too will be under attack. Attacks are becoming more sophisticated and socially engineered making them harder to detect.
The study authors concluded that "Medicaid enrollees on paper have stronger network adequacy protections than QHP enrollees" referring to those who are covered by Qualified Health Plans through ACA Marketplaces. However, standards differ dramatically at the state level.
Pfizer is already in the mix of companies pursuing vaccines for respiratory syncytial virus. The pharma giant is now broadening its scope with a deal to acquire ReViral Therapeutics, a biotech with two clinical-stage antivirals, each taking a different approach to stopping the potentially deadly pathogen.
The latest generation of health and wellness offerings enables employers to provide tailored solutions to their workforce. These apps and programs often leverage big data analytics and the human touch to both identify and connect with employees.
No comments